# EDGAR Filing Document

**Accession Number:** 0000050863
**File Stem:** 0000000000-25-005804
**Filing Date:** 2025-6
**Character Count:** 6455
**Document Hash:** bc3075e68f7dfa2eefe2f5fda5c424da
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-25-005804.hdr.sgml**: 20250827

**ACCESSION NUMBER**: 0000000000-25-005804

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250602

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** INTEL CORP
- **CENTRAL INDEX KEY:** 0000050863
- **STANDARD INDUSTRIAL CLASSIFICATION:** SEMICONDUCTORS & RELATED DEVICES [3674]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 941672743
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1227

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 000-06217

**BUSINESS ADDRESS:**
- **STREET 1:** 2200 MISSION COLLEGE BLVD
- **STREET 2:** RNB-4-151
- **CITY:** SANTA CLARA
- **STATE:** CA
- **ZIP:** 95054
- **BUSINESS PHONE:** 4087658080

**MAIL ADDRESS:**
- **STREET 1:** 2200 MISSION COLLEGE BLVD
- **STREET 2:** RNB-4-151
- **CITY:** SANTA CLARA
- **STATE:** CA
- **ZIP:** 95054
**PUBLIC REFERENCE ACCESSION NUMBER**: 0000050863-25-000009

## Text-Extract

```

                                                            June 2, 2025

David Zinsner
Chief Financial Officer
Intel Corporation
2200 Mission College Boulevard
Santa Clara, California 95054

       Re: Intel Corporation
           Form 10-K for the Fiscal Year Ended December 28, 2024
           Filed January 31, 2025
           File No. 000-06217
Dear David Zinsner:

       We have limited our review of your filing to the financial statements
and related
disclosures and have the following comments.

       Please respond to this letter within ten business days by providing the
requested
information or advise us as soon as possible when you will respond. If you do
not believe a
comment applies to your facts and circumstances, please tell us why in your
response.

       After reviewing your response to this letter, we may have additional
comments.

Form 10-K for the Fiscal Year Ended December 28, 2024
Management's Discussion & Analysis
Critical Accounting Estimates, page 30

1.     We note the Critical Accounting Estimates section of your document
refers readers to
       certain financial statement footnotes. Please note, the critical
accounting estimates
       section of MD&A is intended to highlight those financial statement items
that require
       significant management estimates and judgement. Your disclosure should
provide
       comprehensive and meaningful disclosure which considers the following:

             the method(s) used to determine critical accounting estimates;
             the accuracy of past estimates or assumptions;
             the extent to which the estimates or assumptions have changed;
             the drivers that affect variability; and
             which estimates or assumptions are reasonably likely to change in
the future.
 June 2, 2025
Page 2

       Refer to the guidance in SEC Release No. 33-10890 and Item 303(b)(3) of
Regulation
       S-K. Please note that Instruction 3 to Item 303(b) states that critical
accounting
       estimates should supplement but not duplicate the description of
accounting policies
       or other disclosures in the notes to the financial statements. Include
expanded
       disclosures in future filings and provide us with your proposed
disclosure
       enhancements as part of your response.
2.     We note you have sustained goodwill impairment charges in fiscal year
2024. In
       addition, we note that your auditor has included Goodwill Impairment
Assessment as
       a critical audit matter in their audit opinion. We further note
significant continuing
       impairment indicators such as the carrying value of your net assets
substantially
       exceeding your market capitalization at December 28, 2024. Please expand
your
       critical accounting estimates disclosure to include a discussion of your
estimates and
       assumptions pertaining to goodwill, beyond your disclosures included in
Note 11 on
       page 83. Your disclosures should identify the number of reporting units
where
       goodwill is allocated and tested for impairment. Additionally, indicate
whether the
       fair value substantially exceeds book value for all reporting units at
the date of your
       most recent test. If the fair value of any reporting unit does not
substantially exceed
       book value, identify the reporting unit and provide the following:

             the percentage by which fair value exceeded carrying value at the
date of the most
           recent test;
             the amount of goodwill allocated to the reporting unit;
             a detailed description of the methods and key assumptions used and
how the key
           assumptions were determined;
             a discussion of the degree of uncertainty associated with the
assumptions; and
             a description of potential events and/or changes in circumstances
that could
           reasonably be expected to negatively affect the key assumptions.

       Please include expanded disclosures in future filings and provide us
with your
       proposed disclosure enhancements as part of your response.
Notes to Consolidated Financial Statements
Note 3 - Operating Segments, page 68

3.     We note your disclosure in the penultimate paragraph on page 69 which
states "our
       CODMs do not regularly review or receive discrete asset information by
operating
       segment". Given your significant investments in Intel Foundry in recent
years, please
       clarify to us what you mean by "discrete asset information" and confirm
your CODMs
       do not receive total asset information by segment. If your CODMs do not
receive and
       review total asset information by segment, disclose the reason
therefore, refer to ASC
       280-10-50-26.
 June 2, 2025
Page 3

        In closing, we remind you that the company and its management are
responsible for
the accuracy and adequacy of their disclosures, notwithstanding any review,
comments,
action or absence of action by the staff.

       Please contact Andi Carpenter at 202-551-3645 or Kevin Stertzel at
202-551-3723
with any questions.

                                                          Sincerely,

                                                          Division of
Corporation Finance
                                                          Office of
Manufacturing

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._